Nancy Denyes
General Counsel · aTYR PHARMA INC
- 2026
- Feb 5, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nancy Denyes files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Paul Schimmel - $50K in ATYR purchases and sales in the last 12 months
- Sanjay Shukla - $4K in ATYR purchases and sales in the last 12 months
- Jill Marie Broadfoot - $2K in ATYR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nancy Denyes?
Nancy Denyes is a corporate insider, tracked as General Counsel of aTYR PHARMA INC (ATYR). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Nancy Denyes last file a Form 4?
The most recent primary Form 4 on record is dated 5 February 2026, one of 2 filings going back to 2026.
Has Nancy Denyes been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($1K) across all tracked filings.
